We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EPD:NYSEEnterprise Products Partners L.P. Analysis

Data as of 2026-03-31 - not real-time

$37.87

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Enterprise Products Partners is trading at a price of $37.87, comfortably above its 20‑day SMA of 37.72 and the 50‑day SMA of 36.10, while staying below the 200‑day SMA of 32.72, indicating a bullish technical backdrop. The MACD histogram is positive (0.01) and the signal line is bullish, the RSI sits at 54.6 and volume is on an upward trend, all pointing to continued short‑term momentum. Fundamental metrics show a P/E of 14.2 versus an industry average of 23.4, suggesting the stock is undervalued relative to peers, and the forward P/E of 12.2 adds further upside potential. Dividend yield remains attractive at 5.57% with a payout ratio of 81.2%, though free cash flow is thin, raising questions about long‑term sustainability. Recent analyst upgrades from Wells Fargo and Scotiabank, along with inclusion in high‑dividend lists, reinforce a positive sentiment and a modest upside of roughly 1.7% based on current support at 36.36 and resistance at 39.74. However, the company carries a high debt load (debt‑to‑equity > 110) and modest free cash flow, which temper the bullish outlook.
Overall, EPD presents a blend of value and income appeal: the stock is technically bullish, fundamentally cheap, and offers a high dividend, but investors should monitor leverage and cash‑flow sufficiency. The medium‑term horizon may see price pressure near the resistance level, while the long‑term case hinges on the company’s ability to service debt and maintain cash‑flow stability amid regulatory and sector‑specific risks.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish technical indicators (MACD, RSI, rising volume)
  • Analyst upgrades and positive sentiment
  • Proximity to support level offering upside

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • High dividend yield offset by limited free cash flow
  • Elevated debt-to-equity ratio increasing financial risk
  • Potential price ceiling at resistance around $39.74

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued valuation relative to industry peers
  • Stable contract‑based midstream cash flows
  • Attractive dividend yield for income‑focused investors

Key Metrics & Analysis

Financial Health

Revenue Growth-2.90%
Profit Margin11.05%
P/E Ratio14.2
ROE19.50%
ROA5.61%
Debt/Equity113.94
P/B Ratio2.8
Op. Cash Flow$8.6B
Free Cash Flow$22.3M
Industry P/E23.4

Technical Analysis

TrendBullish
RSI54.6
Support$36.36
Resistance$39.74
MA 20$37.72
MA 50$36.10
MA 200$32.72
MACDBullish
VolumeIncreasing
Fear & Greed Index75.34

Valuation

Target Price$38.52
Upside/Downside1.73%
GradeUndervalued
TypeValue
Dividend Yield5.57%

Risk Assessment

Beta0.37
Volatility18.49%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.